The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.

As promised, federal health officials this week dropped longstanding recommendations that healthy children and healthy ...

Several mRNA vaccine trials found a debilitating side effect, and now the Trump administration is cutting funding for more ...

The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older and those 12 to ...

The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing ...

Moderna Inc. gained US approval for a new Covid vaccine for a narrower group of people, in the latest sign that regulators ...

Moderna (MRNA) stock in focus as the U.S. FDA approved its next-gen COVID-19 vaccine, mNEXSPIKE,. Read more here.

NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.

The U.S. Food and Drug Administration has approved Moderna’s next-generation COVID-19 vaccine for everyone aged ...

The US FDA has approved Moderna's next-generation COVID-19 vaccine for adults aged 65 and older, marking a significant stride ...

The US Food and Drug Administration has approved Moderna’s next-generation COVID-19 vaccine, mNEXSPIKE, for individuals aged ...